IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER
Adult Acute Lymphoblastic Leukemia in Remission
National Cancer Institute (NCI)monoclonal_antibodyPhase 2Dormant
BB
65/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 50/ 100
- Competitive Position
- 89/ 100
Competitive context
74 Active assets in the Adult Acute Lymphoblastic Leukemia in Remission cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
MERCAPTOPURINE ANHYDROUS Shanxi Bethune Hospital | Phase 4 | A |
METHOTREXATE PETHEMA Foundation | Phase 4 | BBB |
Cyclophosphamide The First Affiliated Hospital of Zhengzhou University | Phase 4 | BBB |
Cytosin-Arabinosid PETHEMA Foundation | Phase 4 | BBB |
DEXAMETHASONE Shanxi Bethune Hospital | Phase 4 | BBB |
View all 50 →
Same molecule, other indications
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →